Home: Maucher Jenkins

Intellectual Property

Intellectual
Property

Patents | Trade Marks | Designs

Our People

Maucher Jenkins has built a team of outstanding professionals, recognised experts in intellectual property law, science and technology, working across multiple industry sectors and legal jurisdictions.

Dr. Ulrike Kaufmann (née Zorr)

Associate - Patents/Trade Marks

Qualification:
Attorney at Law

Law, Albert Ludwigs University; Doctorate in Patent Law, Institute of Commercial Law, Labour Law and Social Law, Albert-Ludwigs-University Freiburg

Languages:
English
German

 

Dr. Ulrike Kaufmann studied law at the Albert-Ludwigs-University in Freiburg, specialising in intellectual property law. After completing her studies, she worked as a research associate at the Institute for Commercial Law, Labour Law and Social Law, Dept. 4: Intellectual Property Law of Prof. dr. Maximilian Haedicke in Freiburg. She did her doctorate there in the field of patent law and Second Medical Use patents.

 

As part of her legal clerkship, Ulrike gained practical experience in the field of patent litigation at an international law firm, both at one of the German offices and at the London office, as part of her elective rotation.

 

Dr. Ulrike Kaufmann is a lecturer at the Verwaltungs- und Wirtschaftsakademie (VWA) in Freiburg in the field of law. She has been part of our Freiburg team since October 2019.

 

Publications:

 

2020: Aktuelle Entwicklungen rund um den FRAND-Einwand, GRUR-Prax 2020, 73-75 (together with Dr. Michael Nielen)

 

2019: Pregabalin and Fulvestrant – a comparison of German and English liability regimes of Swiss-type-claims in light of current case law; Journal of Intellectual Property Law & Practice, 06/2019, Pages 487-493 (together with Dr. Marco Stief)

 

2019: Pregabalin and Fulvestrant – a comparison of German and English liability regimes of Swiss-type-claims in light of current case law; Journal of Intellectual Property Law & Practice, 06/2019, Pages 487-493 (together with Dr. Marco Stief)

 

2019: Zwischen Pregabalin und Fulvestrant – Ein Vergleich des deutschen und englischen Haftungsregimes bei Swiss-type-claims anlässlich aktueller Rechtsprechung, GRUR 2019, 260-264 (together with Dr. Marco Stief)

 

2018: Second medical use zwischen swiss-type-claim, skinny label und cross-label-use, GRUR Newsletter 01/2018

 

2018: Der Schutzbereich von Patenten auf eine zweite medizinische Indikation im Falle eines cross-label-use, Eine rechtsvergleichende Analyse unter Begutachtung der deutschen, englischen und niederländischen Rechtsprechung (Dissertation), Carl Heymans Verlag

 

Back to search
C
This site uses cookies.

Some of these cookies are essential, while others help us to improve your experience by providing insights into how the site is being used. For more detailed information on the cookies we use, please check our Privacy Policy

Necessary Cookies

Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

Analytical Cookies

Analytical cookies help us to improve our website by collecting and reporting information on its usage.

x